0
Reviews
Efficacy of Zinc Against Common Cold Viruses: An Overview
Darrell Hulisz, PharmD
J Am Pharm Assoc (2003) 2004;44:594-603. doi:10.1331/1544-3191.44.5.594.Hulisz

Abstract

Objective  To review the laboratory and clinical evidence of the medicinal value of zinc for the treatment of the common cold.

Data Sources  Published articles identified through Medline (1980–2003) using the search terms zinc, rhinovirus, and other pertinent subject headings. Additional sources were identified from the bibliographies of the retrieved articles.

Study Selection  By the author.

Data Extraction  By the author.

Data Synthesis  Human rhinoviruses, by attaching to the nasal epithelium via the intracellular adhesion molecule-1 (ICAM-1) receptor, cause most colds. Ionic zinc, based on its electrical charge, also has an affinity for ICAM-1 receptor sites and may exert an antiviral effect by attaching to the ICAM-1 receptors in the rhinovirus structure and nasal epithelial cells. Clinical tests of zinc for treatment of common colds have been inconsistent, primarily because of study design, blinding, and lozenge contents. Early formulations of lozenges also were unpalatable. In three trials with similar study designs, methodologies, and efficacy assessments, zinc effectively and significantly shortened the duration of the common cold when it was administered within 24 hours of the onset of symptoms. Recent reports of trials with zinc gluconate administered as a nasal gel have supported these findings; in addition, they have shown that treatment with zinc nasal gel is effective in reducing the duration and severity of common cold symptoms in patients with established illness.

Conclusion  Clinical trial data support the value of zinc in reducing the duration and severity of symptoms of the common cold when administered within 24 hours of the onset of common cold symptoms. Additional clinical and laboratory evaluations are warranted to further define the role of ionic zinc for the prevention and treatment of the common cold and to elucidate the biochemical mechanisms through which zinc exerts its symptom-relieving effects.

Topics

common cold ; zinc
Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Farr BM, Conner EM, Betts RF, et al. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.  Antimicrob Agents Chemother.  1987;31:1183–7.[PubMed][CrossRef]
 
Fendrick AM.  Viral respiratory infections due to rhinoviruses: current knowledge, new developments.  Am J Ther.  2003;10:193–202.[PubMed]
 
Heikkinen T, Järvinen A. The common cold.  Lancet.  2003;361:51–9.[PubMed]
 
Merluzzi VJ, Cipriano D, McNeil D, et al. Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro.  Res Comm Chem Pathol Pharmacol.  1989;66:425–40.
 
Novick SG, Godfrey JC, Godfrey NJ, et al. How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action.  Med Hypotheses.  1996;46:295–302.[PubMed]
 
 Sugarman B. Zinc and infection.  Rev Infect Dis. 1983;5:137–47.[PubMed]
 
Bashford CL, Alder GM, Graham JM, et al. Ion modulation of membrane permeability: effect of cations on intact cells and on cells and phospholipid bilayers treated with pore-forming agents.  J Membrane Biol.  1988;103:79–94.
 
Bashford CL, Alder GM, Menestrina G, et al. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents.  J Biol Chem. 1986;261:9300–8.[PubMed]
 
Bashford CL, Menestrina G, Henkart PA, Pasternak CA.  Cell damage by cytolysin. Spontaneous recovery and reversible inhibition by divalent cations.  J Immunol.  1988;141:3965–74.[PubMed]
 
Pasternak CA.  Virus, toxin, complement: common actions and their prevention by Ca2+ or Zn2+.  Bioassays.  1987;6:14–9.
 
Turner RB.  The treatment of rhinovirus infections: progress and potential.  Antiviral Res.  2001;49:1–14.[PubMed]
 
Novick SG, Godfrey JC, Pollack RL, et al. Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants.  Med Hypotheses.  1997;49:347–57.[PubMed]
 
van de Stolpe A, van der Saag PT.  Intercellular adhesion molecule-1.  J Mol Med.  1996;74:13–33.[PubMed]
 
Bella J, Kolatkar PR, Marlor CW, et al. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand.  Proc Natl Acad Sci USA.  1998;95:4140–5.[PubMed]
 
Mossad SB.  Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults.  QJM.  2003;96:35–43.[PubMed]
 
Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate.  Ann Intern Med.  2000;133:245–52.[PubMed]
 
Eby GA, Davis DR, Halcomb WW.  Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.  Antimicrob Agents Chemother.  1984;25:20–4.[PubMed]
 
Mossad SB, Macknin ML, Medendorp SV, et al. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.  Ann Intern Med.  1996;125:81–8.[PubMed]
 
Al-Nakib W, Higgins PG, Barrow I, et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges.  J Antimicrob Chemother.  1987;20:893–901.[PubMed]
 
Douglas RM, Miles HB, Moore BW, et al. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults.  Antimicrob Agents Chemother.  1987;31:1263–5.[PubMed]
 
Smith DS, Helzner EC, Nuttall CE Jr, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections.  Antimicrob Agents Chemother.  1989;33:646–8.[PubMed]
 
Weismann K, Jakobsen JP, Weismann JE, et al. Zinc gluconate lozenges for common cold. A double-blind clinical trial.  Dan Med Bull.  1990;37:279–81.[PubMed]
 
Godfrey JC, Sloane BC, Smith DS, et al. Zinc gluconate and the common cold: a controlled clinical study.  J Intern Med Res.  1992;20:234–46.
 
Petrus EJ, Lawson KA, Bucci LR, et al. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects.  Curr Ther Res.  1998;59:595–607.
 
Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children. A randomized controlled trial.  JAMA.  1998;279:1962–7.[PubMed]
 
Turner RB, Cetnarowski WE.  Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds.  Clin Infect Dis.  2000;31:1202–8.[PubMed]
 
Belongia EA, Berg R, Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults.  Am J Med.  2001;111:103–8.[PubMed]
 
Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial.  Ear Nose Throat J.  2000;79:778–80,782.[PubMed]
 
Turner RB.  Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.  Clin Infect Dis.  2001;33:1865–70.[PubMed]
 
Jackson JL, Peterson C, Lesho E. A meta-analysis of zinc salts lozenges and the common cold.  Arch Intern Med.  1997;157:2373–6.[PubMed]
 
Eby GA.  Elimination of efficacy by additives in zinc acetate lozenges for common colds [letter].  Clin Infect Dis.  2001;32:1520.[PubMed]
 
Rutty CJ.  The middle-class plague: epidemic polio and the Canadian State, 1936–1937.  Canadian Bull Med Hist.  1996;13:277–314.
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints